REPH

NASDAQ

Recro Pharma Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2014

News25/Ratings1

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.

Latest news

25 items

799d13D/G
SEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)
SC 13G/A - Societal CDMO, Inc. (0001588972) (Subject)
799d13D/G
SEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)
SC 13G/A - Societal CDMO, Inc. (0001588972) (Subject)
807dINSIDER
Lake Ryan David covered exercise/tax liability with 1,022 shares, decreasing direct ownership by 0.13% to 800,557 units (SEC Form 4)
4 - Societal CDMO, Inc. (0001588972) (Issuer)
818dINSIDER
Enloe J David Jr was granted 196,474 shares, increasing direct ownership by 18% to 1,295,414 units (SEC Form 4)
4 - Societal CDMO, Inc. (0001588972) (Issuer)
818dINSIDER
Lake Ryan David was granted 110,025 shares and covered exercise/tax liability with 37,453 shares, increasing direct ownership by 10% to 801,579 units (SEC Form 4)
4 - Societal CDMO, Inc. (0001588972) (Issuer)
821dINSIDER
Lake Ryan David covered exercise/tax liability with 34,096 shares, decreasing direct ownership by 4% to 729,007 units (SEC Form 4)
4 - Societal CDMO, Inc. (0001588972) (Issuer)
840dINSIDER
Lake Ryan David covered exercise/tax liability with 1,419 shares, decreasing direct ownership by 0.19% to 763,103 units (SEC Form 4)
4 - Societal CDMO, Inc. (0001588972) (Issuer)
856dINSIDER
Lake Ryan David covered exercise/tax liability with 5,690 shares, decreasing direct ownership by 0.74% to 764,522 units (SEC Form 4)
4 - Societal CDMO, Inc. (0001588972) (Issuer)
871dINSIDER
Lake Ryan David covered exercise/tax liability with 1,197 shares, decreasing direct ownership by 0.16% to 770,212 units (SEC Form 4)
4 - Societal CDMO, Inc. (0001588972) (Issuer)
877dSEC
Recro Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
8-K - Societal CDMO, Inc. (0001588972) (Filer)
897dSEC
SEC Form 10-Q filed by Recro Pharma Inc.
10-Q - Societal CDMO, Inc. (0001588972) (Filer)
897dSEC
Recro Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Societal CDMO, Inc. (0001588972) (Filer)
903dINSIDER
Lake Ryan David covered exercise/tax liability with 1,198 shares, decreasing direct ownership by 0.16% to 771,409 units (SEC Form 4)
4 - Societal CDMO, Inc. (0001588972) (Issuer)
932dINSIDER
Lake Ryan David covered exercise/tax liability with 1,198 shares, decreasing direct ownership by 0.15% to 772,607 units (SEC Form 4)
4 - Societal CDMO, Inc. (0001588972) (Issuer)
946dSEC
Recro Pharma Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Societal CDMO, Inc. (0001588972) (Filer)
961dINSIDER
SEC Form 4: Lake Ryan David covered exercise/tax liability with 1,197 shares, decreasing direct ownership by 0.15% to 773,805 units
4 - Societal CDMO, Inc. (0001588972) (Issuer)
966d13D/G
SEC Form SC 13G filed by Recro Pharma Inc.
SC 13G - Societal CDMO, Inc. (0001588972) (Subject)
969dINSIDER
SEC Form 4: Ashton William bought $10,111 worth of shares (22,222 units at $0.46), increasing direct ownership by 9% to 263,622 units
4 - Societal CDMO, Inc. (0001588972) (Issuer)
969dINSIDER
SEC Form 4: Reasons Bryan M. bought $25,000 worth of shares (62,500 units at $0.40), increasing direct ownership by 27% to 291,049 units
4 - Societal CDMO, Inc. (0001588972) (Issuer)
969dINSIDER
SEC Form 4: Weisman Wayne bought $25,000 worth of shares (62,500 units at $0.40), increasing direct ownership by 25% to 308,602 units
4 - Societal CDMO, Inc. (0001588972) (Issuer)
969dINSIDER
SEC Form 4: Miller James Charles bought $15,000 worth of shares (37,500 units at $0.40), increasing direct ownership by 20% to 227,543 units
4 - Societal CDMO, Inc. (0001588972) (Issuer)
969dINSIDER
SEC Form 4: Cant Elena bought $12,000 worth of shares (30,000 units at $0.40), increasing direct ownership by 41% to 103,620 units
4 - Societal CDMO, Inc. (0001588972) (Issuer)
969dINSIDER
SEC Form 4: Churchill Winston J bought $25,000 worth of shares (62,500 units at $0.40), increasing direct ownership by 26% to 301,602 units
4 - Societal CDMO, Inc. (0001588972) (Issuer)
969dINSIDER
SEC Form 4: Awm Investment Company, Inc. bought $56,000 worth of shares (140,000 units at $0.40)
4 - Societal CDMO, Inc. (0001588972) (Issuer)
972dSEC
SEC Form 424B5 filed by Recro Pharma Inc.
424B5 - Societal CDMO, Inc. (0001588972) (Filer)